Get started
Author

Avania Bangalee

Observed names: A Bangalee, Bangalee, Avania
Institution: Lancet Laboratories
ORCID: 0000-0003-3643-3038
Observed ORCID: 0000-0003-3643-3038
OpenAlex ID: A5035770685
Fake news and fallacies: Exploring vaccine hesitancy in South Africa
2021 · Avania Bangalee, Varsha Bangalee · South African Family Practice · 35
PDF
Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa
2021 · Avania Bangalee, Lucia Hans, et al. · Journal of Antimicrobial Chemotherapy · 20
MEDICINE AND THE LAW: Dolutegravir as first-line antiretroviral therapy in South Africa: Beware the one-size-fits-all approach
2022 · A Bangalee, S Hanley, et al. · South African Medical Journal · 15
PDF
Evaluation of serological assays for the diagnosis of HIV infection in adults
2021 · Avania Bangalee, Sachin Bhoora, et al. · South African Family Practice · 11
PDF
Laboratory Considerations for Reporting Cycle Threshold Value in COVID-19.
2022 · Rivak Punchoo, Sachin Bhoora, et al. · PubMed · 4
Riding the waves: Challenges to medical specialty training during the COVID-19 pandemic in South Africa
2022 · A Bangalee, V Bangalee · African Journal of Health Professions Education · 1
Hepatitis C missed diagnostic opportunities: The role of reflex viral load testing in the era of direct acting antivirals, a descriptive South African study from 2017 to 2021
2026 · Hloniphile Mthiyane, Bonolo Mashishi, et al. · Southern African Journal of Infectious Diseases
PDF
A pandemic guided by the SARS-CoV-2 PCR test: What should the clinician know?
2022 · Avania Bangalee, Kreshalen Govender, et al. · South African Family Practice
PDF
Works count: 9
Citation count: 86
H-index: 4
I10-index: 4
Year
Topic
Type